Literature DB >> 18704308

The effect of targeted magnetic nanopaticles on hepatoma and the expression of bcl-2/bax protein.

Jianming Wang1, Baolai Xiao, Jianwei Zheng, Shengquan Zou.   

Abstract

The effect of targeted magnetic nanoparticles on hepatoma and the underlying mechanism were examined. Nude mice transplanted with a human hepatoma cell line (HepG2 cells) were randomized into 5 groups, including: (1) group A, receiving normal saline, (2) group B, receiving 5-fluorouracil (5-Fu), (3) group C, receiving magnetic nanoparticles containing 5-Fu, (4) group D, consisting of treatment with magnetic nanoparticles containing 5-Fu and inside magnetic field and (5) group E, receiving pure magnetic nanoparticles and inside magnetic field. Morphological features of transplanted tumors in mice in each group were observed under transmission electron microscope (TEM). The expression of bcl-2/bax protein was immunohistochemically detected by SABC method. The results showed that a large number of apoptotic tumor cells were found in group B and group D under TEM. The expression of bcl-2 protein was significantly decreased and the expression of bax protein increased significantly in both group B and D as compared with those in group A, C and E (P<0.01 for all). The decrease in bcl-2 and the increase in bax were more in group D as compared with group B (P<0.01). It is concluded that the targeted magnetic nanoparticles containing 5-Fu can improve the chemotherapeutic effect of 5-Fu by decreasing bcl-2 expression, increasing bax expression and inducing apoptosis of the liver cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704308     DOI: 10.1007/s11596-008-0415-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  21 in total

1.  Recurrence after resection of alpha-fetoprotein-positive hepatocellular carcinoma.

Authors:  X D Zhou; Z Y Tang; Y Q Yu; B H Yang; J Z Lu; Z Y Lin; Z C Ma; B H Zhang
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

2.  Dynamic expression of apoptosis-related genes during development of laboratory hepatocellular carcinoma and its relation to apoptosis.

Authors:  Xiao-Xian Duan; Jing-Sheng Ou; Yuan Li; Jian-Jia Su; Chao Ou; Chun Yang; Hui-Fen Yue; Ke-Chen Ban
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

3.  The irinotecan/5-fluorouracil combination induces apoptosis and enhances manganese superoxide dismutase activity in HT-29 human colon carcinoma cells.

Authors:  Ivana Grivicich; Andréa Regner; Adriana B da Rocha; Guilherme B Kayser; Daniel P Schunemann; Luciano B Grass; Pedro A G Alves; João A P Henriques; Gilberto Schwartsmann
Journal:  Chemotherapy       Date:  2005-05-09       Impact factor: 2.544

4.  The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated.

Authors:  A R Gottschalk; L H Boise; Z N Oltvai; M A Accavitti; S J Korsmeyer; J Quintáns; C B Thompson
Journal:  Cell Death Differ       Date:  1996-01       Impact factor: 15.828

5.  c-Myc functionally cooperates with Bax to induce apoptosis.

Authors:  Philippe Juin; Abigail Hunt; Trevor Littlewood; Beatrice Griffiths; Lamorna Brown Swigart; Stanley Korsmeyer; Gerard Evan
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

6.  The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors.

Authors:  Takayuki Kogure; Yoshiyuki Ueno; Takao Iwasaki; Toru Shimosegawa
Journal:  Cancer Chemother Pharmacol       Date:  2003-12-20       Impact factor: 3.333

7.  Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.

Authors:  M M Keane; S A Ettenberg; M M Nau; E K Russell; S Lipkowitz
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

Review 8.  Apoptosis. Its significance in cancer and cancer therapy.

Authors:  J F Kerr; C M Winterford; B V Harmon
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

9.  Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.

Authors:  Xiaojuan Yan; Michael Fraser; Qing Qiu; Benjamin K Tsang
Journal:  Gynecol Oncol       Date:  2006-03-20       Impact factor: 5.482

10.  Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.

Authors:  E Yang; J Zha; J Jockel; L H Boise; C B Thompson; S J Korsmeyer
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

View more
  1 in total

1.  Effects of ursolic acid on the proliferation and apoptosis of human ovarian cancer cells.

Authors:  Xianghong Wang; Liling Li; Bo Wang; Jinyi Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.